SCHEMBL16410602

SCHEMBL16410602

Clc1cccc(C2(N=NC3=Nc4ccccc4NC34CCNCC4)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ACAT2 Q9BWD1 2/20 0.43
▸ CYP1A2 P05177 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ TACR1 P25103 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410830 0.80 ACAT2 (0.57) ACAT2CYP1A2CHRM2CHRM4CYP3A4
SCHEMBL17757761 0.74 ACAT2 (0.43) ACAT2CYP1A2CHRM2CHRM4CYP3A4
SCHEMBL16410766 0.73 ACAT2 (0.47) ACAT2CYP1A2CYP3A4CYP2D6CHRM1
SCHEMBL16410652 0.73 PDE7A (0.38) ACAT2KDM4EMAPT
SCHEMBL16410816 0.72 ACAT2 (0.45) ACAT2CYP1A2CYP3A4CYP2D6
SCHEMBL16410759 0.72 ACAT2 (0.57) ACAT2KDM4EMAPT
SCHEMBL16410532 0.72 ACAT2 (0.44) ACAT2TACR1MAPT
SCHEMBL16410750 0.71 ACAT2 (0.39) ACAT2CYP1A2CYP3A4CYP2D6CHRM1
SCHEMBL17757281 0.70 ACAT2 (0.53) ACAT2MAPT
SCHEMBL29823199 0.70 ACAT2 (0.53) ACAT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback